Jacques Belaiche
Overview
Explore the profile of Jacques Belaiche including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
3059
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Vos M, Louis E, Jahnsen J, Vandervoort J, Noman M, Dewit O, et al.
Inflamm Bowel Dis
. 2013 Jul;
19(10):2111-7.
PMID: 23883959
Background: This study examined whether fecal calprotectin can be used in daily practice as a marker to monitor patients with ulcerative colitis (UC) receiving infliximab maintenance therapy. Methods: This prospective...
2.
Reenaers C, Belaiche J, Louis E
World J Gastroenterol
. 2012 Aug;
18(29):3823-7.
PMID: 22876033
Crohn's disease and ulcerative colitis are progressive diseases associated with a high risk of complications over time including strictures, fistulae, perianal complications, surgery, and colorectal cancer. Changing the natural history...
3.
Putzeys V, Gerard C, Bastens B, Wain E, Bataille C, Defrance P, et al.
Acta Gastroenterol Belg
. 2011 Aug;
74(2):277-80.
PMID: 21861311
Background And Aim: Hepatitis C virus genotype 2 is the third in order of frequency in Belgium. The aim of this study was to better define the genotype 2 carriers'...
4.
Reenaers C, Louis E, Belaiche J
Therap Adv Gastroenterol
. 2010 Dec;
3(2):99-106.
PMID: 21180594
Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory bowel diseases which can be difficult to control with conventional therapies. A greater understanding of their pathophysiology has led to...
5.
Louis E, Belaiche J, Reenaers C
Therap Adv Gastroenterol
. 2010 Dec;
2(4):239-44.
PMID: 21180546
Crohn's disease is a heterogeneous disease with approximately 30-40% of patients having a simple benign history and the rest having a chronic progressive disease leading to complications, surgeries and potentially...
6.
Louis E, Belaiche J, Reenaers C
World J Gastroenterol
. 2010 Jun;
16(21):2600-3.
PMID: 20518080
While therapeutic strategies able to change the natural history of the disease are developing, it is of major importance to have available predictive factors for aggressive disease to try and...
7.
Louis E, Belaiche J, Reenaers C
Curr Drug Targets
. 2010 Mar;
11(2):148-51.
PMID: 20210763
When to stop anti-TNF therapy in Crohn's disease (CD)? This is a very important question both for patients and physicians. There is no published evidence to clearly and definitely answer...
8.
Imielinski M, Baldassano R, Griffiths A, Russell R, Annese V, Dubinsky M, et al.
Nat Genet
. 2009 Nov;
41(12):1335-40.
PMID: 19915574
The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis are common causes of morbidity in children and young adults in the western world. Here we report the results of...
9.
Villani A, Lemire M, Louis E, Silverberg M, Collette C, Fortin G, et al.
PLoS One
. 2009 Sep;
4(9):e7154.
PMID: 19784369
Background And Aims: The familial Mediterranean fever (FMF) gene (MEFV) encodes pyrin, a major regulator of the inflammasome platform controlling caspase-1 activation and IL-1beta processing. Pyrin has been shown to...
10.
Louis E, Libioulle C, Reenaers C, Belaiche J, Georges M
Gut
. 2009 Aug;
58(9):1173-6.
PMID: 19671546
No abstract available.